Vaccines get help from tobacco plants
TEXT OF STORY
Bill Radke: We learned the importance of vaccine supply last year with the H1N1 scare. The global market for vaccines is expected to soon top $30 billion. Now a new technology could change this fast-growing market entirely. Marketplace’s Stacey Vanek-Smith reports.
Stacey Vanek-Smith: Epidemics and the threat of bioterrorism have drug companies and governments pouring money into vaccine research. This week, the Department of Defense announced it’s backing a plan to grow vaccines on a type of tobacco plant-not the kind you smoke.
Brett Giroir is a doctor and vaccine expert at Texas A&M University:
Brett Giroir: Plants are very good at making a lot of vaccine very, very rapidly. Plants have the promise to cut months off of the vaccine development timeline. And also to be able to do it much more cost-effectively.
Now, most vaccines are produced in chicken eggs-which takes a lot of time and costs a lot of money.
Barry Holtz is the president of G-Con, which developed a technique for growing vaccines on tobacco plants:
Barry Holtz: What it’s going to mean is we’re going to be able to respond much more quickly to pandemic or bioterrorism event or other things that would require a vaccine.
Holtz says they’re moving fast, but the technology is at least a few years away from market.
I’m Stacey Vanek-Smith for Marketplace.
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.
